E
Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
E
Sell
3/14/2023Downgrade
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 02/09/2023.
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index and total return index.
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
5/16/2022Upgraded
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 05/16/2022.
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 5/13/2022 due to a decline in the growth index and volatility index. Total revenue declined 75.4% from $435 to $107.
Biora Therapeutics, Inc. (BIOR) was downgraded to E+ from D on 5/13/2022 due to a decline in the growth index and volatility index. Total revenue declined 75.4% from $435 to $107.
D
Sell
5/4/2022Upgraded
Biora Therapeutics, Inc. (PROG) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
Biora Therapeutics, Inc. (PROG) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
Biora Therapeutics, Inc. (PROG) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
Biora Therapeutics, Inc. (PROG) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 04/21/2022.
Biora Therapeutics, Inc. (BIORQ) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Progenity, Inc. (PROG) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index and total return index.
Progenity, Inc. (PROG) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell
11/15/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D from E+ on 11/15/2021 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.2282 to -$0.4564, and EBIT increased 14.28% from -$35.65M to -$30.56M.
Progenity, Inc. (PROG) was upgraded to D from E+ on 11/15/2021 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.2282 to -$0.4564, and EBIT increased 14.28% from -$35.65M to -$30.56M.
E
Sell
11/8/2021Downgrade
Progenity, Inc. (PROG) was downgraded to E+ from D- on 11/8/2021 due to a decline in the valuation index.
Progenity, Inc. (PROG) was downgraded to E+ from D- on 11/8/2021 due to a decline in the valuation index.
D
Sell
10/14/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D- from E+ on 10/14/2021 due to an increase in the volatility index.
Progenity, Inc. (PROG) was upgraded to D- from E+ on 10/14/2021 due to an increase in the volatility index.
E
Sell
9/29/2021Downgrade
Progenity, Inc. (PROG) was downgraded to E+ from D- on 9/29/2021 due to a decline in the volatility index.
Progenity, Inc. (PROG) was downgraded to E+ from D- on 9/29/2021 due to a decline in the volatility index.
D
Sell
9/10/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D- from E+ on 9/10/2021 due to an increase in the volatility index.
Progenity, Inc. (PROG) was upgraded to D- from E+ on 9/10/2021 due to an increase in the volatility index.
E
Sell
8/25/2021Downgrade
Progenity, Inc. (PROG) was downgraded to E+ from D- on 8/25/2021 due to a decline in the volatility index and total return index.
Progenity, Inc. (PROG) was downgraded to E+ from D- on 8/25/2021 due to a decline in the volatility index and total return index.
D
Sell
8/18/2021Downgrade
Progenity, Inc. (PROG) was downgraded to D- from D on 8/18/2021 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.5602 to -$1.2282, the quick ratio declined from 0.98 to 0.83, and EBIT declined 13.31% from -$31.46M to -$35.65M.
Progenity, Inc. (PROG) was downgraded to D- from D on 8/18/2021 due to a major decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.5602 to -$1.2282, the quick ratio declined from 0.98 to 0.83, and EBIT declined 13.31% from -$31.46M to -$35.65M.
D
Sell
8/5/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D from D- on 8/5/2021 due to an increase in the volatility index.
Progenity, Inc. (PROG) was upgraded to D from D- on 8/5/2021 due to an increase in the volatility index.
D
Sell
7/21/2021Downgrade
Progenity, Inc. (PROG) was downgraded to D- from D on 7/21/2021 due to a decline in the volatility index and total return index.
Progenity, Inc. (PROG) was downgraded to D- from D on 7/21/2021 due to a decline in the volatility index and total return index.
D
Sell
7/1/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D from D- on 7/1/2021 due to an increase in the volatility index.
Progenity, Inc. (PROG) was upgraded to D from D- on 7/1/2021 due to an increase in the volatility index.
D
Sell
5/14/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D- from E+ on 5/14/2021 due to a major increase in the growth index and solvency index. Total revenue increased 71.8% from $14.28M to $24.53M, earnings per share increased from -$1.5324 to -$0.5612, and operating cash flow increased 30.68% from -$70.06M to -$48.56M.
Progenity, Inc. (PROG) was upgraded to D- from E+ on 5/14/2021 due to a major increase in the growth index and solvency index. Total revenue increased 71.8% from $14.28M to $24.53M, earnings per share increased from -$1.5324 to -$0.5612, and operating cash flow increased 30.68% from -$70.06M to -$48.56M.
E
Sell
5/3/2021Downgrade
Progenity, Inc. (PROG) was downgraded to E+ from D- on 5/3/2021 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from -$1.0093 to -$1.5324, total revenue declined 44.97% from $25.94M to $14.28M, and operating cash flow declined 36.61% from -$51.28M to -$70.06M.
Progenity, Inc. (PROG) was downgraded to E+ from D- on 5/3/2021 due to a substantial decline in the growth index, volatility index and total return index. Earnings per share declined from -$1.0093 to -$1.5324, total revenue declined 44.97% from $25.94M to $14.28M, and operating cash flow declined 36.61% from -$51.28M to -$70.06M.
D
Sell
3/1/2021Upgraded
Progenity, Inc. (PROG) was upgraded to D- from E on 3/1/2021 due to an increase in the volatility index.
Progenity, Inc. (PROG) was upgraded to D- from E on 3/1/2021 due to an increase in the volatility index.
E
Sell
12/1/2020Upgraded
Progenity, Inc. (PROG) was upgraded to E from E- on 12/1/2020 due to a large increase in the growth index. Earnings per share increased from -$6.1068 to -$1.0093, total revenue increased 50.25% from $17.27M to $25.94M, and EBIT increased 4.6% from -$46.72M to -$44.57M.
Progenity, Inc. (PROG) was upgraded to E from E- on 12/1/2020 due to a large increase in the growth index. Earnings per share increased from -$6.1068 to -$1.0093, total revenue increased 50.25% from $17.27M to $25.94M, and EBIT increased 4.6% from -$46.72M to -$44.57M.
E
Sell
9/14/2020None
Biora Therapeutics, Inc. (BIORQ) was downgraded to E- from U on 09/14/2020.
Biora Therapeutics, Inc. (BIORQ) was downgraded to E- from U on 09/14/2020.
OTC PK
03/07/2025 10:36AM Eastern
Quotes delayed
